ESC Premium Access

The future of lipid management: new therapies for LDL-C lowering

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Sponsored by National Lipid Association

Congress Presentation

About the speaker

Doctor Harold Bays

Louisville Metabolic and Atherosclerosis Research Center, Louisville (United States of America)
1 presentation
0 follower

4 more presentations in this session

Clinical implications for patients at persistent ASCVD risk

Speaker: Doctor J. Saseen (Aurora, US)


Clinical trial updates

Speaker: Doctor C. Ballantyne (Houston, US)


Post-activity quiz and discussion

Speaker: Doctor P. MORRIS (Charleston, US)


Questions and answers / Panel discussion


Access the full session

Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

Speakers: Doctor H. Bays, Doctor J. Saseen, Doctor C. Ballantyne, Doctor P. MORRIS

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by